These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7314156)

  • 1. Effects of 4-hydroxy-4-androstene-3, 17-dione and 10-propargylestr-4-ene-3, 17-dione on the metabolism of androstenedione in human breast carcinoma and breast adipose tissues.
    Perel E; Davis SP; Covey DF; Killinger DW
    Steroids; 1981 Oct; 38(4):397-405. PubMed ID: 7314156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
    MacIndoe JH; Woods GR; Etre LA; Covey DF
    Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of in vivo administration of 10-propargylestr-4-ene-3,17-dione on rat ovarian aromatase and estrogen levels.
    Brandt ME; Covey DF; Zimniski SJ
    J Enzyme Inhib; 1990; 4(2):143-52. PubMed ID: 2098521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 1,4,6-androstatriene-3,17-dione (ATD), 4-hydroxy-4-androstene-3,17-dione (4-OH-A) and 4-acetoxy-4-androstene-3,17-dione (4-Ac-A) on the 5 alpha-reduction of androgens in the rat prostate.
    Motta M; Zoppi S; Brodie AM; Martini L
    J Steroid Biochem; 1986 Oct; 25(4):593-600. PubMed ID: 3773531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor.
    Zimniski SJ; Brandt ME; Covey DF; Puett D
    Breast Cancer Res Treat; 1993; 26(1):15-21. PubMed ID: 8400320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of peripheral aromatization in baboons by an enzyme-activated aromatase inhibitor (MDL 18,962).
    Longcope C; Femino A; Johnston JO
    Endocrinology; 1988 May; 122(5):2007-11. PubMed ID: 3359974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Leydig tumor cell steroidogenesis by 10-propargylestr-4-ene-3,17-dione, an irreversible aromatase inhibitor.
    Zimniski SJ; Brandt ME; Melner MH; Covey DF; Puett D
    Cancer Res; 1985 Oct; 45(10):4883-9. PubMed ID: 4027975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of peripheral aromatization by aromatase inhibitors, 4-hydroxy- and 4-acetoxy-androstene-3,17-dione.
    Brodie AM; Longcope C
    Endocrinology; 1980 Jan; 106(1):19-21. PubMed ID: 6765930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of aromatase activity and of endocrine-responsive tumor growth by 10-propargylestr-4-ene-3, 17-dione and its 17-propionate derivative.
    Zimniski SJ; Brandt ME; Covey DF; Puett D
    Steroids; 1987; 50(1-3):135-46. PubMed ID: 3504057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue.
    Perel E; Killinger DW
    J Steroid Biochem; 1983 Aug; 19(2):1135-9. PubMed ID: 6193342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen metabolism in male and female breast tissue.
    Perel E; Davis S; Killinger DW
    Steroids; 1981 Mar; 37(3):345-52. PubMed ID: 7233457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of 19-hydroxy- 19-oxo-, and aromatizing-activities in human placental microsomes through the use of suicide substrates to aromatase.
    Bednarski PJ; Nelson SD
    J Steroid Biochem; 1989 Feb; 32(2):309-16. PubMed ID: 2921872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrone formation from dehydroepiandrosterone in cultured human breast adipose stromal cells.
    Killinger DW; Strutt BJ; Roncari DA; Khalil MW
    J Steroid Biochem Mol Biol; 1995 Feb; 52(2):195-201. PubMed ID: 7873453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of estrogen synthesis in human breast tumors by testololactone and bromoandrostenedione.
    Budnick RM; Dao TL
    Steroids; 1980 May; 35(5):533-41. PubMed ID: 7394858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 19-hydroxy-delta4-androstene-3,17-dione in the conversion of circulating delta4-androstene-3, 17-dione to estrone.
    Kelly WG; De Leon O; Rizkallah TH
    J Clin Endocrinol Metab; 1976 Jul; 43(1):190-4. PubMed ID: 947937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatization of delta4-androstene-3,17-dione, 19-hydroxy-delta4-androstene-3,17-dione, and 19-oxo-delta4-androstene-3,17-dione at a common catalytic site in human placental microsomes.
    Kelly WG; Judd D; Stolee A
    Biochemistry; 1977 Jan; 16(1):140-5. PubMed ID: 831774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer.
    Brodie AM; Schwarzel WC; Shaikh AA; Brodie HJ
    Endocrinology; 1977 Jun; 100(6):1684-95. PubMed ID: 404132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of aromatase activity and growth suppression by 4-methoxy-4-androstene-3,17-dione in an androgen sensitive human prostatic carcinoma cell line.
    Block JL; Block NL; Lokeshwar BL
    Cancer Lett; 1996 Mar; 101(2):143-8. PubMed ID: 8620462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intracellular control of aromatase activity by 5 alpha-reduced androgens in human breast carcinoma cells in culture.
    Perel E; Stolee KH; Kharlip L; Blackstein ME; Killinger DW
    J Clin Endocrinol Metab; 1984 Mar; 58(3):467-72. PubMed ID: 6693545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The conversion of androstenedione to estrone, estradiol, and testosterone in breast tissue.
    Perel E; Wilkins D; Killinger DW
    J Steroid Biochem; 1980 Jan; 13(1):89-94. PubMed ID: 7382486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.